Last Day to Register for the Johnson & Johnson Innovation Digital Health Masterclass

Over 100 of Europe's best digital health companies have already asked to take part in the Johnson & Johnson Digital Health Masterclass and an impressive line up of some of Europe's foremost experts in healthcare, technology, business strategy and venture capital is in place to help companies deliver on their growth agenda.

Executives from the selected digital health companies will have the opportunity to enjoy the benefits of a growth-focused curriculum, expert advice, and close interaction with venture and angel financing partners. Launched in July, in partnership with Health 2.0, the Masterclass offers an opportunity for executives to take their businesses to the next level and to raise their profile with key influencers in the field of digital health.

The programme modules will include:

Session 1, Berlin - September 18th to 20th 2013

  • Clear evidence-based case for healthcare transformation and digital health
  • Detailed look at G5 Healthcare markets & innovation programmes
  • Examination of regulatory issues and compliance for digital health companies
  • Strategy Exercise- identifying core capabilities required to maintain strategic advantage

Session 2, Barcelona - October 9th to 11th 2013

  • Business model development, excercise, and expert review
  • Developing detailed growth-focused business models and related operational plans
  • Deep dive on technology and trends in each of the primary Digital Health technology verticals
  • Introduction on scaling business operations

Session 3, London - October 28th to 30th 2013

  • Scaling product and service delivery
  • Developing trials and data sets to support "evidence based" sales
  • Building executive teams, boards, and advisors that can help you scale
  • Power of Story- build a powerful company story that connects with investors and customers
  • Financing your company's growth

The programme will culminate in an Investor Day on November 20th in London, run in partnership with local venture capitalists, healthcare providers and technology companies, the day will also provide significant networking opportunities. All companies will be able to meet and to forge their own relationships directly with prospective investors and customers.

9th of August is the closing date for applications - successful applicants will not only have the opportunity to share a prize pool of €50k, they will also have a rare chance to interact with leading voices from business, healthcare, and technology.

Format: Companies selected for the Masterclass will attend a series of three 3-day workshops run in partnership with local healthcare and technology companies. Networking sessions will be held in the evening at each location

Dates: September 18th to November 20th

Workshops: European locations, finishing in London.

Challenge and Investor Day, London - 20th November 2013 in association with Health 2.0 Europe

For further information, please visit:
http://masterclass.jnjinnovation.com

Related news articles:

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...